GLP-1 and GIP agonists are typically prescribed for people with type 2 diabetes or patients that are overweight (meeting the criteria), or obese patients
Liposomal glutathione wraps the molecule in a fat-soluble coating
In a blood analysis of 60 participants with type 2 diabetes and 24 healthy controls, the researchers in China found that Ffar4 mutations, which reduce FGF21 production, are linked to an increased preference for sugar, "which may be an important contributor to the development of diabetes." What's more, the gut microbiome could be a key mediator of that process
CVS Caremark, which manages prescription benefits for the school system, did not return a request for comment
Rodent studies showed dose-dependent thyroid C-cell tumors with liraglutide and semaglutide, though human relevance is still under study
doi: 10.1016/j.dld.2009.08.002 31 BedogniGBellentaniSMiglioliLMasuttiFPassalacquaMCastiglioneAet al